[18F]FDOPA positron emission tomography for cardiac innervation imaging: a new way or a dead-end street?

[1] Chondrogiannis S(2013)Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging Nucl Med Commun 34 1141-1149

[2] Marzola MC(2020)EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. Eur J Nucl Med Mol Imaging 47 1885-1912

[3] Al-Nahhas A(2021)PET with different radiopharmaceuticals in neuroendocrine neoplasms: an umbrella review of published meta-analyses Cancers 13 5172-1379

[4] Venkatanarayana TD(2012)Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis Pediatr Radiol 42 1372-3869

[5] Mazza A(2019)Diagnostic performance and prognostic value of PET/CT with different tracers for brain tumors: a systematic review of published meta-analyses Int J Mol Sci 20 4669-98

[6] Opocher G(2022)Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 Eur J Nucl Med Mol Imaging 49 3852-55

[7] Rubello D(2022)What new can we learn from cardiac sympathetic neuroimaging in synucleinopathies? Clin Auton Res 32 95-490

[8] Morbelli S(2020)Cardiac sympathetic innervation imaging with PET radiotracers Curr Cardiol Rep 23 4-494

[9] Esposito G(2012)MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis Clin Auton Res 22 43-1290

[10] Arbizu J(2021)The role of myocardial innervation imaging in different clinical scenarios: an expert document of the European Association of Cardiovascular Imaging and Cardiovascular Committee of the European Association of Nuclear Medicine Eur Heart J Cardiovasc Imaging 22 480-undefined

[1] Chondrogiannis S(2013)Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging Nucl Med Commun 34 1141-1149

[2] Marzola MC(2020)EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. Eur J Nucl Med Mol Imaging 47 1885-1912

[3] Al-Nahhas A(2021)PET with different radiopharmaceuticals in neuroendocrine neoplasms: an umbrella review of published meta-analyses Cancers 13 5172-1379

[4] Venkatanarayana TD(2012)Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis Pediatr Radiol 42 1372-3869

[5] Mazza A(2019)Diagnostic performance and prognostic value of PET/CT with different tracers for brain tumors: a systematic review of published meta-analyses Int J Mol Sci 20 4669-98

[6] Opocher G(2022)Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 Eur J Nucl Med Mol Imaging 49 3852-55

[7] Rubello D(2022)What new can we learn from cardiac sympathetic neuroimaging in synucleinopathies? Clin Auton Res 32 95-490

[8] Morbelli S(2020)Cardiac sympathetic innervation imaging with PET radiotracers Curr Cardiol Rep 23 4-494

[9] Esposito G(2012)MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis Clin Auton Res 22 43-1290

[10] Arbizu J(2021)The role of myocardial innervation imaging in different clinical scenarios: an expert document of the European Association of Cardiovascular Imaging and Cardiovascular Committee of the European Association of Nuclear Medicine Eur Heart J Cardiovasc Imaging 22 480-undefined